Jw Pharmaceutical

This study tested a new medicine called JW0201 for people with type 2 diabetes whose blood sugar was still too high despite taking other specific medications. About 196 participants were randomly assigned to receive either the new drug or a placebo (a dummy pill) for 24 weeks. Th…

This study observed what happens when patients with high cholesterol switch from taking just a statin medication to taking a combination of two cholesterol-lowering drugs (pitavastatin and ezetimibe). It followed nearly 7,000 adults for 24 weeks to see if the combination was more…

This completed Phase 3 trial tested whether giving two drugs together (JW0108 and C2407) is effective and safe for people with dyslipidemia, a condition of unhealthy cholesterol levels. The main goal was to see how much the treatment lowered 'bad' LDL cholesterol. The study invol…

This study looked at how well the cholesterol-lowering drug Livalozet works and how safe it is for people with high cholesterol. It specifically compared results between patients who also have diabetes and those who do not. Researchers observed over 1,500 patients for 24 weeks to…

This study tested a new medicine called JW0201 for people with type 2 diabetes whose blood sugar was still too high despite taking two other specific drugs. About 200 participants were randomly assigned to receive either JW0201 or a placebo (a dummy pill) in addition to their cur…

This study aimed to understand how two new drugs, JW0104/C2402 and JW0105, are processed by the body and to check their safety. It involved 60 healthy volunteers who received single doses. The main goal was to measure drug levels in the blood over time, not to treat any disease.

This study aimed to understand how the body processes two common heart medications—one for high cholesterol and one for high blood pressure—when taken as separate pills versus as a single combined pill. It involved 52 healthy male volunteers who received the drugs in different se…